BridgeBio Pharma, Inc. (BBIO)
68.05
+4.32
(+6.78%)
USD |
NASDAQ |
Feb 06, 16:00
68.05
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Price : 68.05 for Feb. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 328.16 |
| Sarepta Therapeutics, Inc. | 18.50 |
| Cidara Therapeutics, Inc. | 221.38 |
| Cogent Biosciences, Inc. | 37.08 |
| Olema Pharmaceuticals, Inc. | 25.36 |
Price Related Metrics
| PS Ratio | 36.64 |
| PEG Ratio | -0.2209 |
| Earnings Yield | -6.15% |
| Market Cap | 13.11B |
| PEGY Ratio | -0.2209 |